Something structural is happening at the intersection of maternal and pediatric health tech. In Q4 2025 and Q1 2026, we tracked 23 funding rounds totaling $1.7 billion across companies explicitly positioned on the full maternal-pediatric continuum.
Eight deals across maternal-pediatric health tech this week, led by Zarminali's $110M Series C and Pomelo Care's milestone round that values the company above $1 billion.
The One Big Beautiful Bill Act's Medicaid provisions have moved from political debate to operational reality. Here's the specific exposure for maternal-pediatric health tech companies and what the most prepared operators are doing about it.
A $310M behavioral health week capped a strong month for mental health and women's health funding. What the deal terms reveal about where institutional money is going in 2026.
A comprehensive look at the companies building technology for neonatal intensive care — from AI-assisted monitoring to family communication platforms to post-discharge support. Which segments have traction, where the whitespace remains.
Six deals this week, plus a regulatory update: the FTC's revised COPPA rules take effect in 60 days. Here's which categories of pediatric health tech products have the most exposure.
After years of false starts, value-based care for children is showing genuine commercial traction. We analyze the model variations, the payer dynamics, and the companies positioned to benefit as Medicaid and commercial payers accelerate the shift.
Seven deals this week, including an unusual strategic pivot from Clarity Pediatrics into GLP-1 management for children and Conceivable Life Sciences' fully-automated IVF laboratory round.